Tuesday, 04 September 2018 14:03

ASM Members Awarded Kavli Prize in Nanoscience

Written by 
Published in ASM News

Emmanuelle Charpentier of the Max Planck Institute for Infection Biology, an ASM member, and Jennifer Doudna of the University of California, Berkeley, a fellow of the American Academy of Microbiology, were awarded the Kavli Prize in Nanoscience “for the invention of CRISPR-Cas9, a precise nanotool for editing DNA, causing a revolution in biology, agriculture, and medicine.” “CRISPR-Cas9 confers to society enormous capabilities for positive innovations. Possible benefits are wide-ranging in scope and value. CRISPR-Cas9 is a breakthrough nanotool that will considerably enhance our understanding of genetic mechanisms,” said Arne Brataas, chair of the nanoscience prize committee, in a statement.

The winners were honored today in Norway during a gala ceremony hosted by King Harald V, part of a week of events celebrating all seven 2018 Kavli prize winners. Virginijus Šikšnys of Vilnius University in Lithuania, another early CRISPR researcher, shared the honor with Doudna and Charpentier. The Norwegian Academy of Science and Letters selected the laureates and the three award winners shared a cash prize of $1 million and received gold medals.

Kavli nanoscience

Emmanuelle Charpentier and Jennifer Doudna receiving the prize from King Harald V.

Last modified on Wednesday, 05 September 2018 09:07